Cargando…
Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes
[Image: see text] Octahedral Pt(IV) complexes (2Pt–R) containing a glycoconjugate carbene ligand were prepared and fully characterized. These complexes are structural analogues to the trigonal bipyramidal Pt(II) species (1Pt–R) recently described. Thus, an unprecedented direct comparison between the...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997382/ https://www.ncbi.nlm.nih.gov/pubmed/32129608 http://dx.doi.org/10.1021/acs.inorgchem.9b03683 |
_version_ | 1783670316287918080 |
---|---|
author | Annunziata, Alfonso Amoresano, Angela Cucciolito, Maria Elena Esposito, Roberto Ferraro, Giarita Iacobucci, Ilaria Imbimbo, Paola Lucignano, Rosanna Melchiorre, Massimo Monti, Maria Scognamiglio, Chiara Tuzi, Angela Monti, Daria Maria Merlino, Antonello Ruffo, Francesco |
author_facet | Annunziata, Alfonso Amoresano, Angela Cucciolito, Maria Elena Esposito, Roberto Ferraro, Giarita Iacobucci, Ilaria Imbimbo, Paola Lucignano, Rosanna Melchiorre, Massimo Monti, Maria Scognamiglio, Chiara Tuzi, Angela Monti, Daria Maria Merlino, Antonello Ruffo, Francesco |
author_sort | Annunziata, Alfonso |
collection | PubMed |
description | [Image: see text] Octahedral Pt(IV) complexes (2Pt–R) containing a glycoconjugate carbene ligand were prepared and fully characterized. These complexes are structural analogues to the trigonal bipyramidal Pt(II) species (1Pt–R) recently described. Thus, an unprecedented direct comparison between the biological properties of Pt compounds with different oxidation states and almost indistinguishable structural features was performed. The stability profile of the novel Pt(IV) compounds in reference solvents was determined and compared to that of the analogous Pt(II) complexes. The uptake and antiproliferative activities of 2Pt–R and 1Pt–R were evaluated on the same panel of cell lines. DNA and protein binding properties were assessed using human serum albumin, the model protein hen egg white lysozyme, and double stranded DNA model systems by a variety of experimental techniques, including UV–vis absorption spectroscopy, fluorescence, circular dichroism, and electrospray ionization mass spectrometry. Although the compounds present similar structures, their in-solution stability, cellular uptake, and DNA binding properties are diverse. These differences may represent the basis of their different cytotoxicity and biological activity. |
format | Online Article Text |
id | pubmed-7997382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-79973822021-03-29 Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes Annunziata, Alfonso Amoresano, Angela Cucciolito, Maria Elena Esposito, Roberto Ferraro, Giarita Iacobucci, Ilaria Imbimbo, Paola Lucignano, Rosanna Melchiorre, Massimo Monti, Maria Scognamiglio, Chiara Tuzi, Angela Monti, Daria Maria Merlino, Antonello Ruffo, Francesco Inorg Chem [Image: see text] Octahedral Pt(IV) complexes (2Pt–R) containing a glycoconjugate carbene ligand were prepared and fully characterized. These complexes are structural analogues to the trigonal bipyramidal Pt(II) species (1Pt–R) recently described. Thus, an unprecedented direct comparison between the biological properties of Pt compounds with different oxidation states and almost indistinguishable structural features was performed. The stability profile of the novel Pt(IV) compounds in reference solvents was determined and compared to that of the analogous Pt(II) complexes. The uptake and antiproliferative activities of 2Pt–R and 1Pt–R were evaluated on the same panel of cell lines. DNA and protein binding properties were assessed using human serum albumin, the model protein hen egg white lysozyme, and double stranded DNA model systems by a variety of experimental techniques, including UV–vis absorption spectroscopy, fluorescence, circular dichroism, and electrospray ionization mass spectrometry. Although the compounds present similar structures, their in-solution stability, cellular uptake, and DNA binding properties are diverse. These differences may represent the basis of their different cytotoxicity and biological activity. American Chemical Society 2020-03-04 2020-03-16 /pmc/articles/PMC7997382/ /pubmed/32129608 http://dx.doi.org/10.1021/acs.inorgchem.9b03683 Text en Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Annunziata, Alfonso Amoresano, Angela Cucciolito, Maria Elena Esposito, Roberto Ferraro, Giarita Iacobucci, Ilaria Imbimbo, Paola Lucignano, Rosanna Melchiorre, Massimo Monti, Maria Scognamiglio, Chiara Tuzi, Angela Monti, Daria Maria Merlino, Antonello Ruffo, Francesco Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes |
title | Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor
Agents: Minimal Structural Variations and Great Performance Changes |
title_full | Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor
Agents: Minimal Structural Variations and Great Performance Changes |
title_fullStr | Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor
Agents: Minimal Structural Variations and Great Performance Changes |
title_full_unstemmed | Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor
Agents: Minimal Structural Variations and Great Performance Changes |
title_short | Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor
Agents: Minimal Structural Variations and Great Performance Changes |
title_sort | pt(ii) versus pt(iv) in carbene glycoconjugate antitumor
agents: minimal structural variations and great performance changes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997382/ https://www.ncbi.nlm.nih.gov/pubmed/32129608 http://dx.doi.org/10.1021/acs.inorgchem.9b03683 |
work_keys_str_mv | AT annunziataalfonso ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT amoresanoangela ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT cucciolitomariaelena ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT espositoroberto ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT ferrarogiarita ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT iacobucciilaria ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT imbimbopaola ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT lucignanorosanna ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT melchiorremassimo ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT montimaria ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT scognamigliochiara ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT tuziangela ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT montidariamaria ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT merlinoantonello ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges AT ruffofrancesco ptiiversusptivincarbeneglycoconjugateantitumoragentsminimalstructuralvariationsandgreatperformancechanges |